Trius Therapeutics Inc
DelistedCIK 1356857fmd_14VQXV645JVJKF8FFDBTZMA3JPManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2013, 14 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|
| Total revenues | 5 | 8 | 41 | 27 |
| Research and development | 23 | 23 | 50 | 69 |
| Total operating expenses | 27 | 29 | 61 | 84 |
| Operating income | (22) | (21) | (20) | (57) |
| Interest expense | 0 | 4 | – | – |
| Interest and investment income | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (1) | (3) | 2 | 3 |
| Net income | (23) | (24) | (18) | (54) |
| Net income to common shareholders | (23) | (24) | (18) | (54) |